Log Out

US Stock MarketDetailed Quotes

PFE Pfizer

Watchlist

25.400
+0.140+0.55%

Close Apr 26 16:00 ET

25.440
+0.040+0.16%

Post 19:59 ET

143.83BMarket Cap68.65P/E (TTM)

Pfizer News

News

Announcement

Ratings

All

Earnings

Transactions

Shareholding

Events

Other

Pfizer | 144: Notice of proposed sale of securities pursuant to Rule 144
Sep 13, 2023 15:48 ET
Pfizer | 424B5: Prospectus
May 18, 2023 16:37 ET
Pfizer | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
May 16, 2023 21:31 ET
Pfizer | 424B3: Prospectus
May 15, 2023 07:50 ET
Pfizer | 424B5: Prospectus
Aug 17, 2021 16:02 ET
Pfizer | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Aug 16, 2021 17:07 ET
Pfizer | 424B3: Prospectus
Aug 16, 2021 08:52 ET
Pfizer | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 26, 2020 17:05 ET
Pfizer | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 18, 2020 17:01 ET
Pfizer | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 1, 2020 17:27 ET
Pfizer | 424B5: Prospectus
May 20, 2020 16:31 ET
Pfizer | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
May 18, 2020 20:06 ET
Pfizer | 424B3: Prospectus
May 18, 2020 08:23 ET
Pfizer | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Apr 29, 2020 17:45 ET
Pfizer | 424B5: Prospectus
Mar 26, 2020 16:49 ET
Pfizer | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 26, 2020 16:16 ET
Pfizer | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 25, 2020 17:08 ET
Pfizer | 424B3: Prospectus
Mar 25, 2020 08:54 ET
Pfizer | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Feb 27, 2020 16:18 ET
Pfizer | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Feb 27, 2020 16:18 ET

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

Cancer Research

Cancer Research

CAR-T Therapy